MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

Q: What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in Q1 2018?

98 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share for Q1 2018. Use the holders table for investor-level position and value details.

CUSIP: 558868105

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 22,822,754
Total 13F shares: 6,326,097
Share change: +1,203,921
Total reported value: $738,823,289
Price per share: $116.79
Number of holders: 98
Value change: +$151,724,184
Number of buys: 66
Number of sells: 40

Security key

558868105

Report period

Q1 2018

Institutions

Top holders

MDGL full security history Newer quarter: Q2 2018 Previous quarter: Q4 2017 MADRIGAL PHARMACEUTICALS, INC. SEC filings MADRIGAL PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 558868105

Newer quarter: Q2 2018 Previous quarter: Q4 2017

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	3.1%	717,125	$65,825,000	—	31 Dec 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	2.7%	615,684	$56,514,000	—	31 Dec 2017	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2%	451,500	$41,443,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	1.7%	381,327	$35,002,000	—	31 Dec 2017	13F
Rock Springs Capital Management LP	13F	Company	1.5%	342,000	$31,392,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	1.2%	274,359	$25,184,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	0.92%	209,428	$19,223,000	—	31 Dec 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.89%	204,206	$18,744,000	—	31 Dec 2017	13F
JENNISON ASSOCIATES LLC	13F	Company	0.89%	204,200	$18,744,000	—	31 Dec 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.83%	188,893	$17,338,000	—	31 Dec 2017	13F
Polar Capital LLP	13F	Company	0.79%	180,000	$16,522,000	—	31 Dec 2017	13F
Point72 Asset Management, L.P.	13F	Company	0.53%	120,000	$11,015,000	—	31 Dec 2017	13F
ASCEND CAPITAL, LLC	13F	Company	0.51%	117,494	$10,783,000	—	31 Dec 2017	13F
LORD, ABBETT & CO. LLC	13F	Company	0.45%	102,242	$9,384,000	—	31 Dec 2017	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.42%	95,191	$8,737,000	—	31 Dec 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.38%	87,587	$8,040,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	0.31%	69,753	$6,402,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.29%	65,247	$5,989,000	—	31 Dec 2017	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.26%	60,000	$5,507,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.24%	54,299	$4,984,000	—	31 Dec 2017	13F
Marshall Wace North America L.P.	13F	Company	0.2%	45,785	$4,203,000	—	31 Dec 2017	13F
Informed Momentum Co LLC	13F	Company	0.2%	44,889	$4,120,000	—	31 Dec 2017	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.16%	36,850	$3,382,000	—	31 Dec 2017	13F
EcoR1 Capital, LLC	13F	Company	0.15%	35,000	$3,213,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.14%	30,875	$2,834,000	—	31 Dec 2017	13F
Hudson Bay Capital Management LP	13F	Company	0.13%	30,000	$2,754,000	—	31 Dec 2017	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.11%	25,000	$2,293,000	—	31 Dec 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.11%	24,992	$2,294,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.11%	24,189	$2,220,000	—	31 Dec 2017	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.1%	23,141	$2,124,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.09%	20,268	$1,859,000	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.08%	18,200	$1,671,000	—	31 Dec 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.07%	15,272	$1,402,000	—	31 Dec 2017	13F
ALPS ADVISORS INC	13F	Company	0.06%	13,847	$1,271,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	13,624	$1,249,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.05%	11,900	$1,092,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.04%	10,117	$928,000	—	31 Dec 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.04%	9,561	$878,000	—	31 Dec 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.04%	9,401	$863,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	8,828	$811,000	—	31 Dec 2017	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.04%	8,757	$804,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	7,900	$726,000	—	31 Dec 2017	13F
TEACHERS ADVISORS, LLC	13F	Company	0.03%	7,274	$668,000	—	31 Dec 2017	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	6,600	$606,000	—	31 Dec 2017	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.03%	6,000	$551,000	—	31 Dec 2017	13F
ELLINGTON MANAGEMENT GROUP LLC	13F	Company	0.02%	5,500	$505,000	—	31 Dec 2017	13F
CREDIT SUISSE AG/	13F	Company	0.02%	5,036	$462,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	4,993	$458,000	—	31 Dec 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	4,500	$413,000	—	31 Dec 2017	13F
VIRTUS ADVISERS, LLC	13F	Company	0.02%	4,382	$402,000	—	31 Dec 2017	13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q1 2018

As of 31 Mar 2018, MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,326,097 shares. The largest 10 holders included Capital Research Global Investors, BAKER BROS. ADVISORS LP, STATE STREET CORP, Rock Springs Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., JENNISON ASSOCIATES LLC, and FMR LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

Q1 2018 holders

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.